Mental Health Status of Healthcare Professionals and Students of Health Sciences Faculties in Kuwait during the COVID-19 Pandemic

Kuwait is a Middle Eastern country with an area of 17,820 km² and a population of 4,301,539 people (2020 estimate) [16]. A quantitative, prospective, and cross-sectional study was performed to assess the mental health status of HCPs and HSCUs during the COVID-19 outbreak. It was conducted between May and July 2020. Ethical approval for this study was obtained from the Human Ethical Committee, Health Sciences Centre, Kuwait University (VDR/EC/3655).

The sample size was estimated based on the World Health Organization (WHO) recommendations for the minimal sample size needed for a prevalence study [17]. Using a confidence interval of 95%, a standard deviation of 0.5, and a margin of error of 5%, the required sample size was 385 participants. A convenience sample of eligible participants (HCPs and HSCUs) was invited to participate in the study. Data were collected using two online-administered questionnaires sent through various social media platforms (e.g., Twitter and WhatsApp). Each study population was invited using a specific survey-link (e.g., one for the HCPs and another for HSCUs). All HCPs (n = 9863) who work at the six generalized hospitals, which provided units for COVID-19 patients during the pandemic, were invited [18]. The hospitals were approached by the researcher. The head of each department (e.g., medical/pharmacy/nursing) in these hospitals were visited to help in obtaining WhatsApp addresses of HCPs and distributing the survey-link to them. For HSCUs, the researcher used the official Twitter address of the HSC of Kuwait University to invite them to participate in the study. In addition, one staff member at each faculty invited students in his/her contact list through WhatsApp messages. The inclusion criteria were an age of ≥18 years, living in Kuwait during the pandemic period, and working in governmental hospitals that were operated for the management of COVID-19 patients for HCPs, and studying at HSC of Kuwait University for HSCUs. The study objectives, maintenance of confidentiality, and anonymity were clearly explained at the beginning of the survey. A reminder message was sent to all eligible participants before the end of the data collection period (on 1st of July). All participants voluntarily participated in the study and gave written consent.

Previously validated assessment scales, the Patient Health Questionnaire (PHQ-9) and the Generalized Anxiety Disorder 7-item (GAD-7) were used to assess depression and anxiety among the study’s participants. The study instruments have been used among different populations to assess their mental health status [19,20,21,22]. The PHQ-9 and GAD-7 instruments asked the participants about the degree of applicability of each item (question), using a 4-point Likert scale. Participants’ responses ranged from 0 to 3, where 0 means “Not at all” and 3 means “Nearly every day”. The PHQ-9 is a self-report questionnaire that is commonly used as a screening tool for depression [23]. It is a 9-question instrument to assess the presence and severity of depression [24,25]. Items are scored from 0 to 3 generating a total score ranging from 0 to 27. A total score of 0–4 indicates minimal depression, 5–9 mild depression, 10–14 moderate depression, 15–19 moderately severe depression, and 20–27 severe depression [26]. The GAD-7 instrument includes 7 items, and was initially developed to screen for GAD, and also proved to have good sensitivity and specificity as a screening tool for anxiety, panic, and social disorders [27,28]. Items are scored from 0 to 3 generating a total score ranging from 0 to 21. A total score of 0–4 indicates minimal anxiety, 5–9 mild anxiety, 10–14 moderate anxiety, and 15–21 severe anxiety [29].

The prevalence rates of depression and anxiety were determined using a cut-off point as recommended by the authors of the PHQ-9 and GAD-7 scales. In this study, depression was defined as a total score of 15 or more, which indicates moderately severe or severe depression. Anxiety was defined as a total score of 15 or more, which indicates severe anxiety. The rates were estimated by dividing the number of participants who exceeded the borderline score (15) by the total number of participants in the same population. In addition, demographic information was collected from the participants, such as age, gender, and marital status. All participants were asked whether they were worried about being infected with COVID-19 or transmitting it to family members (yes/no question). Moreover, HCPs were asked about whether they were in direct contact and/or were providing direct or indirect medical care for patients with COVID-19 during this pandemic. Students were asked about their years of study and history of chronic diseases. The questionnaires were pre-tested for content, design, readability, and comprehension on two HCPs and three HSCUs, and minor modifications were included.

Descriptive statistics were used to describe participants’ demographics. Continuous data were reported as median (interquartile range, IQR). Categorical data were reported as percentages (95% confidence interval, CI). Comparative analysis was performed on the depression and anxiety scores across different demographic and other characteristics of respondents using Mann-Whitney and Kruskal–Wallis tests because the data were not normally distributed based on the Shapiro–Wilk and Kolmogorov–Smirnov tests for normality. Logistic regression was used to estimate odds ratios (ORs) with 95% CIs. Logistic regression models were carried out using anxiety or depression scores above the cut-off points for severe cases. A two-sided p < 0.05 was considered statistically significant. The statistical analyses were carried out using the Statistical Package for Social Sciences (IBM Corp, Armonk, NY, SPSS Statistics for Windows, version 25).

A total of 857 responders (HCPs = 559 and HSCUs = 298), 18 years and above, who fully completed the questionnaire were included in the statistical analysis. Table 1 shows the characteristics of the study’s participants. The majority (n = 633, 73.9%) were females, married (n = 425, 49.6%), and with regards to the HCPs, most had a high income (n = 267, 47.8%). Physicians contributed to the largest proportion of the participating HCPs (n = 213, 38.1%) followed by pharmacists (n = 189, 33.8%), allied health professionals (n = 127, 22.7%), and nurses (n = 30, 5.4%). Most of the HCPs (n = 478, 85.5%; 95% CI: 82.3–88.3) reported that they were in direct contact with COVID-19 patients during the pandemic period. In relation to HSCUs, around 33.6% (n = 100) were in their early years, 48% (n = 143) in the middle years, and 18.4% (n = 55) in their final years. Only 15.4% (n = 46; 95% CI: 11.6–20.2) of HSCUs reported a history of chronic disease. The majority of the participants (n = 549, 64.1%; 95% CI: 60.7–67.3) reported that they were concerned about contracting COVID-19 or transmitting it to their family members.

Table 2 shows the prevalence of depression and anxiety among the respondents stratified by their severity. Two-thirds (n = 571; 66.6%; 95% CI: 62.9–69.3) were found to have PHQ-9 scores ≥15, which indicates moderately severe depression or severe depression. The prevalence of mild, moderate, moderately severe, and severe depression among respondents were 3.2%, 28.2%, 35.1%, and 31.5%, respectively. Over one-third (n = 314; 36.7%; 95% CI: 79.4–84.6) had GAD-7 scores ≥15, which indicates severe anxiety. The proportions of mild, moderate, and severe anxiety among respondents were 17.8%, 45.5%, and 36.7% respectively.

Table 3 presents the median (IQR) scores of depression and anxiety stratified by the participants’ characteristics. The median (IQR) PHQ-9 score for depression was significantly higher among HSCUs (20 {11.5}) compared to HCPs (17 {8}); p = 0.006 and females (18 {9}) compared to males (15 {8}); p < 0.001. In HCPs, the median (IQR) PHQ-9 score for depression was significantly higher among those aged 18–29 years (19 {10}) and 30–49 years (17 {8.25}) compared to those aged ≥50 years (15 {8.20}), p < 0.05. In HSCUs, the median (IQR) PHQ-9 score for depression was significantly higher among those aged 18–29 years (20 {11.75}) and students with a history of chronic disease (23.5 {8}) compared to those aged >29 years (18 {11.70}), p = 0.001, and those with no chronic disease history (18 {10}), p = 0.018, respectively. The median (IQR) GAD-7 scores for anxiety were significantly higher among females (14 {7}) compared to males (12 {8}), p < 0.001, and HSCUs with a history of chronic disease (16.5 {2.75}) compared to those with no history of chronic disease (12 {7}), p = 0.017. Interestingly, both populations in the age range of 18–29 years had comparable median depression and anxiety scores. The two populations had the same median anxiety score (13), whereas HSCUs showed higher median depression scores (20 {11.75}) compared to HCPs (19 {10}), p < 0.05.

In addition, those who worried about being infected with COVID-19 or transmitting it to their family members had higher median depression and anxiety scores. Pharmacists and HCPs with high-income levels showed lower median depression scores. Students in their final years had the least median depression and anxiety scores compared to their colleagues in other year levels. However, there were no significant associations between all those variables.

Using logistic regression, among HCPs, the following group were identified to be at higher risk of depression: females, younger than 50 years, who reported that they were in direct contact and provided medical care to COVID-19 patients during the pandemic period (Table 4). Among HSCUs, females who are >29 years were at higher risk of depression, and those who reported a chronic disease history were at higher risk of depression and anxiety (Table 5).

In Japan and Singapore, during the Severe Acute Respiratory Syndrome (SARS) outbreak, fear and anxiety were prevalent among more than half of HCPs [42,43]. In Greece, nearly half of the HCPs experienced moderately high levels of worry during the H1N1 influenza pandemic [44]. In the case of COVID-19, due to its unclear dynamics, rapidity of spread, high morbidity and mortality rates, and the lack of definitive therapy and preventive vaccines, feelings of fear and stress might be exacerbated, contributing to the pressure and anxiety to HCPs [2,6,45]. In China, half of HCPs were identified to suffer from at least mild depression, 45% with moderate or severe anxiety, and one-third with insomnia during the COVID-19 outbreak [46]. HCPs in Oman had high anxiety rates, where 65% suffered from mild, moderate, or severe anxiety during this recent pandemic [47]. In India, HCPs also showed depression and anxiety symptoms (47% and 50%, respectively) during the outbreak of COVID-19 [48]. Consistent with the previous studies, this study found that more than half of HCPs experienced depression and 37.4% experienced anxiety. However, this was not the case in Saudi Arabia, where only 15% of HCPs reported fear and anxiety or considered rescheduling their duty to avoid contact with COVID-19 patients [38]. This could be attributed to the fact that in Saudi Arabia HCPs passed through several campaigns as a part of preparedness for the upcoming pandemic, to improve seasonal influenza uptake during their previous Middle East Respiratory Syndrome (MERS-COV) outbreak. In Jordan, HCPs reported lower depression and anxiety rates compared to HCPs in Kuwait [49]. This could be related to the fact that in Jordan, HCPs experienced fewer cases of COVID-19 due to the rapid proactive measures taken by the government. In Italy, only 20% of HCPs had depression symptoms and 8% had forms of anxiety during the recent COVID-19 outbreak [50]. Mental health responses to epidemics may differ due to several issues including the availability of clinical evidence, media reports, case and death rates, and the implemented isolation policies [2,34].

Unsurprisingly, this study showed that depression and anxiety were more prevalent among HCPs who were in direct contact with confirmed/suspected COVID-19 patients. Similarly, studies during the SARS outbreak and COVID-19 reported more psychiatric symptoms among HCPs who were directly exposed to patients [11,47,51,52,53]. Being isolated or quarantined could provoke lethargy among HCPs [6]. Furthermore, Temsah et al. (2020) reported a small percentage of anxiety and anger feelings (7.6% and 16.6% respectively) among HCPs who worked in quarantines. In regard to the specialty of the HCP, it has been proven in previous studies that during pandemics doctors showed a lower level of anxiety compared to other HCPs [8,46,50]. Although the current findings showed slight differences in depression and anxiety rates, doctors reported lower levels of mental distress compared to other HCPs. However, results reported from India were in opposition those of all of the previous studies, and showed no differences between doctors and nurses in their mental distress level during the pandemic [48].

Regarding the age of HCPs, this study reported similar results to those found in Jordan and other countries, where young HCPs were more psychologically affected than others [12,47,48,49,54]. This could be attributed to the fact that young HCPs may have less experience or they may have such fear because they might be parents of children, and young people who need more attention and effort in improving their knowledge about the preventive measures. In comparison, older HCPs may have more experience, better coping skills, and greater knowledge about pandemics and how to deal with such emergencies, even though older people with comorbidities are particularly vulnerable to worse outcomes from COVID-19, which generate extensive worry and anxiety amongst the elderly. The level of education, training, experience, and knowledge about infectious diseases and their management could positively impact the psychological wellbeing of HCPs [55,56]. Although this was not investigated in the current study, belief in the preventive and control measures applied by the MOH could also contribute to the lower rates of depression and anxiety among HCPs [35]. Similar to recent studies, the current study reported that the female gender was a risk factor for psychological distress among HCPs during pandemics [2,46,47,49,50,54,57]. This could be attributed to the increased frequency of hormonal fluctuation in women, which leads to mood changes compared to men [58,59]. However, Chen and colleagues (2020) and Suryavanshi and colleagues (2020) reported no significant differences in depression and anxiety between male and female HCPs.

Due to the abrupt suspension of education, with no immediate alternative plans to resume lessons, HSCUs showed high depression and anxiety rates. Students might have major concerns regarding the impact of the current emergent situation on their future education and employment [2,60]. In addition, students’ psychological impairment could be related to the fact that during quarantine there was an absence of interpersonal communication [61,62]. Alternatively, it could be that social media use increased among students due to greater availability of free time during the lockdown, resulting in a negative affect via the updated COVID-19 news and cases. In the context of depression, the current study reported higher rates (72.2%) than Jordan (38.5%) and Iran (27.6%) [41,49]. This could be related to the fact that in Jordan and Iran the universities used remote learning methods instantly, whereas in Kuwait, it took several months to decide on continuing education through distance learning. Uncertainty regarding the future and the disruption of daily routine might contribute to high depression rates [63]. Regarding anxiety, this study also reported higher results (35.2%) than Jordan and China, where university students reported anxiety rates of 21.5% and 24.9%, respectively [10,44]. However, medical students in Iran had comparable results for anxiety rates (38%) to students in Kuwait [41].

In this study, all HSCUs who reported a history of chronic disease showed higher depression and anxiety scores compared to their counterparts who do not have a chronic disease. Unsurprisingly, this result could be due to the awareness of the students about the association between the severity of COVID-19 complications and the presence of chronic diseases [64]. Although the type of chronic disease was not investigated in this study, other studies reported a significant association between history of mental illness and anxiety during COVID-19 outbreak among university students [10,65,66]. Female students showed higher depression and anxiety rates, which is consistent with results reported in Iran [41]. A previous study in Kuwait also reported a significant difference in stress rates among female compared to male students [15]. Such findings may indicate that males and females respond variously to stressors. However, in contrast to results reported from China and other countries, male and female students showed no significant differences in their distress level during the COVID-19 outbreak [10,67].

The findings of this study highlighted the impact of the COVID-19 pandemic on the psychological wellbeing of a very important group of the population such as HCPs (who work as front-liners) and HSCUs (who have the ambition to graduate and practice their knowledge in the health sector). These results should raise the awareness of policymakers to propose appropriate interventions that ensure the psychological wellbeing of targeted individuals during the pandemic period. Regular and intensive training for all HCPs on the readiness for pandemics is necessary to improve the experience, skills, and mental wellbeing of HCPs, and to help effectively manage critical situations during the pandemic [64,68]. Although the MOH was highly effective in managing manpower and workforce, and in providing medical supplies and personal protective equipment, during the outbreak, emotional support for HCPs is paramount [44,69]. Psychological support is also crucial for HSCUs, and the university should provide students with psychological assistance, such as a hotline service with psychiatrists to provide them with stress relief activities [11,40,70]. Future qualitative studies are required in this field to help in further exploring and addressing the needs of HCPs and HSCUs during pandemics. In addition, future research could also be conducted to compare depression and anxiety levels among HCPs who work for the management of COVID-19 patients and others who work in other settings that operate regularly during the pandemic.

To our knowledge, this is the first study in Kuwait that investigated the prevalence of depression and anxiety during the COVID-19 pandemic among important population groups (HCPs and HSCUs). It included HCPs from different specialties such as physicians, nurses, and pharmacists working in the governmental hospitals in Kuwait. In addition, data were collected during the peak of the COVID-19 pandemic, which reflects the collection of the most realistic and valid results. Furthermore, the use of previously validated assessment tools is another strength of the study.

However, there are some limitations. Limited studies have discussed the impact of this novel pandemic on mental health globally and in the Middle East, which limited the comparison of this study’s findings with others. In addition, the use of an online survey for data collection may introduce some bias, where some targeted populations may have been missed, or may lead to a low response rate. However, the reason for the low response rate among HCPs could be time constraints and heavy workloads due to the current situation of the pandemic, and it was unclear why some students did not participate. Because of the cross-sectional design, potential changes in depression and anxiety levels over time could not be measured. In addition, this study assessed the prevalence of acute depression and anxiety during the pandemic period, and whether the participants had chronic depression and anxiety was not investigated.

Not applicable.